The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation
NCT ID: NCT05594537
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2022-11-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Monofocal IOLs in Highly Myopic Cataract Patients
NCT06905938
The Long-term Outcome After Toric Intraocular Lens Implantation
NCT05465447
Visual Performance of Multifocal Intraocular Lenses
NCT04913792
Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract
NCT02966496
Clinical Outcomes of Patients Bilaterally Implanted With the TECNIS® Symfony or TECNIS® Symfony Toric Extended Range of Vision IOL
NCT03997890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ZXR00+ZXR00 emmetropia group
The bilateral implantation of ZXR00 IOLs，and emmetropia was considered as the target refraction for both eyes.
No interventions assigned to this group
ZXR00+ZXR00 micromonovision group
The bilateral implantation of ZXR00 IOLs，and the ZXR00 IOLs power calculations were performed using a micro-monovision approach aiming for minimal residual myopia (≈ -0.50 D) in the nondominant eye and emmetropia in the dominant eye.
No interventions assigned to this group
ZXR00ZMB00 group
The blended implantation of bifocal IOLs (ZMB00) and ZXR IOLs.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cataract surgery is planned
* The operation was successful without any complications
* Implanted with ZXR00 IOLS or ZMB00 IOLs
Exclusion Criteria
* Irregular corneal astigmatism
* Regular corneal astigmatism of 1.00 diopter (D) or more
* Iris abnormalities
* Macular degeneration
* Neuro-ophthalmic disease
* The history of ocular inflammation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yune Zhao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yune Zhao
Vice president of Eye Hospital of Wenzhou Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yune Zhao
Role: STUDY_DIRECTOR
Ophthalmology and Optometry Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZXR00-zyy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.